81 FR 70686 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 81, Issue 198 (October 13, 2016)
Centers for Disease Control and Prevention
Federal Register Volume 81, Issue 198 (October 13, 2016)
| Page Range | 70686-70686 | |
| FR Document | 2016-24786 |
[Federal Register Volume 81, Number 198 (Thursday, October 13, 2016)] [Notices] [Page 70686] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2016-24786] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) PAR14-227, Workers' Compensation Surveillance. Time and Date: 1:00 p.m.-6 p.m., EST, November 9, 2016 (Closed) Place: Teleconference Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. Matters For Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``PAR14-227, Workers' Compensation Surveillance, PAR14-227.'' Contact Person For More Information: Michael Goldcamp, Ph.D., Scientific Review Officer, CDC, 1095 Willowdale Road, Morg Building H, Room 1806, Mailstop 1808, Morgantown, WV 26506, Telephone: (304) 285- 5951, [email protected]. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2016-24786 Filed 10-12-16; 8:45 am] BILLING CODE 4163-18-P
![70686 Federal Register / Vol. 81, No. 198 / Thursday, October 13, 2016 / Notices
the webcast can access information at: browser is able to download the files Office, CDC, pursuant to Public Law 92–
http:// from the CDC’s Web site before the 463.
cdclabtraining.adobeconnect.com/ meeting. Matters For Discussion: The meeting
novembercliac/. Alternatively, the files can be will include the initial review,
Online Registration Required: All downloaded to a computer and then discussion, and evaluation of
people attending the CLIAC meeting in- emailed to the portable device. An applications received in response to
person are required to register for the internet connection, power source, and ‘‘PAR14–227, Workers’ Compensation
meeting online at least 5 business days limited hard copies may be available at Surveillance, PAR14–227.’’
in advance for U.S. citizens and at least the meeting location, but cannot be Contact Person For More Information:
10 business days in advance for guaranteed. Michael Goldcamp, Ph.D., Scientific
international registrants. Register at: Contact Person for Additional Review Officer, CDC, 1095 Willowdale
http://wwwn.cdc.gov/cliac/Meetings/ Information: Nancy Anderson, Chief, Road, Morg Building H, Room 1806,
MeetingDetails.aspx. Register by Laboratory Practice Standards Branch, Mailstop 1808, Morgantown, WV 26506,
scrolling down and clicking the Division of Laboratory Systems, Center Telephone: (304) 285–5951, EHG8@
‘‘Register for this Meeting’’ button and for Surveillance, Epidemiology and CDC.GOV.
completing all forms according to the The Director, Management Analysis
Laboratory Services, Office of Public
instructions given. Please complete all and Services Office, has been delegated
Health Scientific Services, Centers for
the required fields before submitting the authority to sign Federal Register
Disease Control and Prevention, 1600
your registration and submit no later notices pertaining to announcements of
Clifton Road NE., Mailstop F–11,
than October 27, 2016 for U.S. meetings and other committee
Atlanta, Georgia 30329; telephone (404)
registrants and October 20, 2016 for management activities, for both the
498–2741; or via email at NAnderson@
international registrants. Centers for Disease Control and
cdc.gov.
Providing Oral or Written Comments: Prevention and the Agency for Toxic
It is the policy of CLIAC to accept The Director, Management Analysis
Substances and Disease Registry.
written public comments and provide a and Services Office, has been delegated
brief period for oral public comments on the authority to sign Federal Register Elaine L. Baker,
agenda items. Public comment periods Notices pertaining to announcements of Director, Management Analysis and Services
for each agenda item are scheduled meetings and other committee Office, Centers for Disease Control and
management activities, for Centers for Prevention.
immediately prior to the Committee
discussion period for that item. Disease Control and Prevention and the [FR Doc. 2016–24786 Filed 10–12–16; 8:45 am]
Oral Comments: In general, each Agency for Toxic Substances and BILLING CODE 4163–18–P
individual or group requesting to make Disease Registry.
oral comments will be limited to a total Elaine L. Baker,
time of five minutes (unless otherwise DEPARTMENT OF HEALTH AND
Director, Management Analysis and Services HUMAN SERVICES
indicated). Speakers must also submit Office, Centers for Disease Control and
their comments in writing for inclusion Prevention. National Institutes of Health
in the meeting’s Summary Report. To [FR Doc. 2016–24785 Filed 10–12–16; 8:45 am]
assure adequate time is scheduled for BILLING CODE 4163–18–P Office of the Director, National
public comments, speakers should Institutes of Health; Notice of Closed
notify the contact person below at least Meeting
one week prior to the meeting date. DEPARTMENT OF HEALTH AND
Written Comments: For individuals or HUMAN SERVICES Pursuant to section 10(d) of the
groups unable to attend the meeting, Federal Advisory Committee Act, as
CLIAC accepts written comments until Centers for Disease Control and amended (5 U.S.C. App.), notice is
the date of the meeting (unless Prevention hereby given of the following meeting.
otherwise stated). However, it is The meeting will be closed to the
requested that comments be submitted Disease, Disability, and Injury public in accordance with the
at least one week prior to the meeting Prevention and Control Special provisions set forth in sections
date so that the comments may be made Emphasis Panel (SEP): Initial Review 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
available to the Committee for their as amended. The grant applications and
consideration and public distribution. In accordance with section 10(a)(2) of the discussions could disclose
Written comments, one hard copy with the Federal Advisory Committee Act confidential trade secrets or commercial
original signature, should be provided (Pub. L. 92–463), the Centers for Disease property such as patentable material,
to the contact person at the mailing or Control and Prevention (CDC) and personal information concerning
email address below, and will be announces a meeting for the initial individuals associated with the grant
included in the meeting’s Summary review of applications in response to applications, the disclosure of which
Report. Funding Opportunity Announcement would constitute a clearly unwarranted
Availability of Meeting Materials: To (FOA) PAR14–227, Workers’ invasion of personal privacy.
support the green initiatives of the Compensation Surveillance.
Name of Committee: Scientific and
federal government, the CLIAC meeting Time and Date: Technical Review Board on Biomedical and
materials will be made available to the 1:00 p.m.–6 p.m., EST, November 9, Behavioral Research Facilities.
Committee and the public in electronic 2016 (Closed) Date: November 9, 2016.
Place: Teleconference Time: 10:00 a.m. to 6:00 p.m.
Lhorne on DSK30JT082PROD with NOTICES
format (PDF) on the internet instead of
by printed copy. Check the CLIAC Web Status: The meeting will be closed to Agenda: To review and evaluate grant
site on the day of the meeting for the public in accordance with applications.
Place: National Institutes of Health, 6701
materials: http://wwwn.cdc.gov/cliac/ provisions set forth in section 552b(c)(4) Rockledge Drive, Bethesda, MD 20892
Meetings/MeetingDetails.aspx. Note: If and (6), title 5 U.S.C., and the (Virtual Meeting).
using a mobile device to access the Determination of the Director, Contact Person: Ross D. Shonat, Ph.D.,
materials, please verify that the device’s Management Analysis and Services Scientific Review Officer, Center for
VerDate Sep<11>2014 14:07 Oct 12, 2016 Jkt 241001 PO 00000 Frm 00023 Fmt 4703 Sfmt 4703 E:\FR\FM\13OCN1.SGM 13OCN1](https://thefederalregister.org/doc/81_FR_70884/page/1.svg)
Document Created: 2016-10-13 00:53:34
Document Modified: 2016-10-13 00:53:34
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| FR Citation | 81 FR 70686 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR